COVID-19 vaccines developed via multiple tech routes in China

October 26, 2022

At least 46 COVID-19 vaccines are being tested in human trials in China and more than 20 in overseas clinical trials as the country pushes forward its vaccine research and development through multiple tech routes.
Cities offer free flu shots as tough winter warned

September 30, 2022

A number of cities in China have started offering free flu shots for the elderly and other vulnerable groups as experts said this winter's flu season could be tough due to declining immunity against the disease and lingering threats posed by the COVID-19 pandemic.
Latest codes of conduct for COVID-19 prevention & control

September 8, 2022

Latest codes of conduct for COVID-19 prevention & control
Oral pill for COVID-19 approved by regulator

July 27, 2022

China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus.
10 years of rural healthcare achievements

July 8, 2022

10 years of rural healthcare achievements
Zhejiang loosens policy on nucleic acid testing

June 10, 2022

Zhejiang's nucleic acid testing policy has been loosened not only for residents in low-risk areas within the province, but also for those coming into the province, the Zhejiang epidemic prevention and control work leading group announced on Tuesday.
Shaoxing residents need to take nucleic acid test every week

June 2, 2022

Shaoxing has now stretched the nucleic acid test interval to seven days, starting May 31.
Chinese-made Omicron vaccine trials get going

May 5, 2022

China began clinical trials for a vaccine designed specifically against the Omicron variant in Hangzhou, Zhejiang province, on Sunday, making it the first vaccine of its kind to enter human trials in the world against the highly transmissible COVID-19 strain.